The ₹500-crore initial public offering (IPO) of speciality chemicals manufacturer Tatva Chintan Pharma Chem was subscribed 182.04 times on the final day of bidding.
The offer received bids for 593.45 million equity shares against 3.26 million on offer, as per subscription data available with the exchanges.
